VanEck ETF Trust - VanEck Biotech ETF
US ˙ NasdaqGM ˙ US92189F7261

SecurityBBH / VanEck ETF Trust - VanEck Biotech ETF
InstitutionIFP Advisors, Inc
Latest Disclosed Ownership40 shares
Latest Disclosed Value $ 7,521
IFP Advisors, Inc ownership in BBH / VanEck ETF Trust - VanEck Biotech ETF

On April 13, 2026 - IFP Advisors, Inc filed a 13F-HR form disclosing ownership of 40 shares of VanEck ETF Trust - VanEck Biotech ETF (US:BBH) valued at $7,521 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on August 14, 2023 disclosing 0 shares of VanEck ETF Trust - VanEck Biotech ETF. The current value of the position is $7,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F VANECK ETF TRUST mc 92189F726 40 40 8 0.0002
2023-08-14 2023-06-30 13F/A-1 VANECK ETF TRUST mc 92189F726 0 -101 -100.00 0 -100.00
2023-08-04 2023-06-30 13F VANECK ETF TRUST mc 92189F726 0 -101 0
2023-04-18 2023-03-31 13F VANECK ETF TRUST mc 92189F726 101 -1,283 -92.70 12 0.0005
2023-02-07 2022-12-31 13F VANECK ETF TRUST mc 92189F726 1,384 -10 -0.72 0 -100.00 0.0044
2022-11-08 2022-09-30 13F VANECK ETF TRUST mc 92189F726 1,394 0 0.00 167 0.00 0.0044
2022-09-06 2022-06-30 13F/A-1 VANECK ETF TRUST mc 92189F726 1,394 0 0.00 167 0.00 0.0054
2022-09-06 2022-03-31 13F/A-1 VANECK ETF TRUST mc 92189F726 1,394 1,394 167 0.0054
2021-07-13 2021-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2021-04-30 2021-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2021-01-25 2020-12-31 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2020-10-29 2020-09-30 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2020-08-05 2020-06-30 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2020-05-12 2020-03-31 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 0 0 0 0.0000
2020-01-17 2019-12-31 13F VANECK VECTORS ETF TRUST BIOTECH ETF CEF 92189F726 0 -745 -100.00 0 -100.00
2019-11-07 2019-09-30 13F VANECK VECTORS ETF TR BIOTECH ETF CEF 92189F726 745 -2,592 -77.67 88 -79.44 0.0059
2019-05-15 2019-03-31 13F VANECK VECTORSBIOTECH ETF ETF 92189F726 3,337 202 6.44 428 24.78 0.0584
2019-06-03 2018-12-31 13F/A-10 MKT VECTORS BIOTECH ETF ETF 92189F726 3,135 -266 -7.82 343 -25.92 0.0209
2019-01-23 2018-12-31 13F MKT VECTORS BIOTECH ETF ETF 92189F726 3,135 -266 343 0.0209
2019-06-03 2018-09-30 13F/A-9 MKT VECTORS BIOTECH ETF ETF 92189F726 3,401 -2,812 -45.26 463 -37.85 0.0189
2018-10-25 2018-09-30 13F MKT VECTORS BIOTECH ETF ETF 92189F726 3,401 -2,812 463 0.0189
2019-06-03 2018-06-30 13F/A-8 MKT VECTORS BIOTECH ETF ETF 92189F726 6,213 770 14.15 745 9.88 0.0313
2018-08-07 2018-06-30 13F MKT VECTORS BIOTECH ETF ETF 92189F726 6,213 535 745
2019-06-03 2018-03-31 13F/A-7 VANECK VECTORS BIOTECH ETF ETF 92189F726 5,443 0 0.00 678 0.00 0.0307
2018-05-09 2018-03-31 13F MKT VECTORS BIOTECH ETF ETF 92189F726 5,678 235 683
2019-06-03 2017-12-31 13F/A-6 VANECK VECTORS BIOTECH ETF ETF 92189F726 5,443 -194 -3.44 678 -10.32 0.0307
2018-01-24 2017-12-31 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 5,443 -194 678
2017-10-30 2017-09-30 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 5,637 1,851 48.89 756 58.82 0.0300
2019-06-03 2017-06-30 13F/A-5 VANECK VECTORS BIOTECH ETF ETF 92189F726 3,786 45 1.20 476 6.97 0.0202
2017-07-31 2017-06-30 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 3,786 45 476
2019-06-03 2017-03-31 13F/A-4 VANECK VECTORS BIOTECH ETF ETF 92189F726 3,741 0 0.00 445 10.70 0.0194
2017-04-26 2017-03-31 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 3,741 0 445
2019-06-03 2016-12-31 13F/A-3 VANECK VECTORS BIOTECH ETF ETF 92189F726 3,741 -1,062 -22.11 402 -27.31 0.0194
2017-02-14 2016-12-31 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 3,741 -1,062 402
2016-11-04 2016-09-30 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 4,803 -2,505 -34.28 553 -26.07 0.0288
2019-06-03 2016-06-30 13F/A-2 VANECK VECTORS BIOTECH ETF ETF 92189F726 7,308 3,971 119.00 748 74.77 0.0418
2016-08-22 2016-06-30 13F VANECK VECTORS BIOTECH ETF ETF 92189F726 7,308 3,971 748
2019-06-03 2016-03-31 13F/A-1 VANECK VECTORSBIOTECH ETF ETF 92189F726 3,337 3,337 428 0.0584
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.